Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-19

Clinical Trial Update: IL-35: A Key Immunosuppressive Driver in Mycosis Fungoides Modulated by Phototherapy [NA]

View source ↗

Summary

A completed clinical trial update investigates interleukin-35 as a key immunosuppressive driver in mycosis fungoides and how phototherapy modulates its activity…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kasr El Aini Hospital | Conditions: Mycosis Fungoides | NA | Status: COMPLETED